blog | Pharmaceuiticals

Skip to content

Login

Login

Subscribe to our Newsletter

Go Back to Home

Go Back to Blog

IPOs, 2026, Avalyn Pharmaceuticals, Inc., Pharmaceuiticals

Avalyn Pharma Sets Terms for ~$200M IPO as Inhaled Pulmonary Fibrosis Platform Targets Treatment Shift

Eric Friedman

Apr 27, 2026 3:48:51 PM

Avalyn Pharma Inc. (Nasdaq: AVLN) has filed to raise approximately $200 million in its upcoming IPO,...

Subscribe to our Newsletter

NONE OF THE CONTENT PUBLISHED ON THE WEBSITE OR MOBILE APP CONSTITUTES A RECOMMENDATION, SOLICITATION, ENDORSEMENT, OR OFFER BY IPO PROPHET™ OR ITS AFFILIATES TO BUY OR SELL ANY SECURITIES, FUTURES, OPTIONS, OR OTHER FINANCIAL INSTRUMENTS, OR PROVIDE ANY INVESTMENT ADVICE OR SERVICE.

Copyright © 2025